SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS

Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

Solid Forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

CRYSTALLINE FORMS OF 8-(2-FLUOROBENZYL)-6-(3-(TRIFLUOROMETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO[1,2-a]PYRAZINE AS sGC STIMULATORS

Polymorphisms of HM30181 Mesylate

METHOD FOR PRODUCING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE

A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF

SOLID FORMS OF 2-(5-(4-(2-MORPHOLINOETHOXY)PHENYL)PYRIDIN-2-YL)-N-BENZYLACETAMIDE

CRYSTALLINE HYDROCHLORIDE SALTS OF N-ETHYL-2-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINE

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

FORMS OF PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES, ITS FORMULATION AND ITS PROCESS OF MAKING

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

PROCESS FOR PREPARING N-(5-(3-(7-(3-FLUOROPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-YL)PYRIDIN-3-YL)-3-METHYLBUTANAMIDE

CRYSTALLINE FORM OF 3- ((L-VALYL) AMINO) -I-PROPANESULFONIC ACID

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

SALT CRYSTAL FORM AND FREE BASE CRYSTAL FORM OF KINASE INHIBITOR

SOLID FORMS OF BERBERINE URSODEOXYCHOLATE AND COMPOSITIONS AND METHODS THEREOF

Nitrile-Containing Antiviral Compounds

SOLID FORMS OF ALPHA-1062 GLUCONATE

2-(1H-IMIDAZOLE-1-CARBONYL)BENZOIC ACID AS AN ANTICANCER COMPOUND

PROCESS FOR PREPARING 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES AND SYNTHETIC INTERMEDIATES THEREOF

Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one

SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS

3-(2-(6-METHOXYPYRIDIN-3-YL)-4,5-DIPHENYL-1H-IMIDAZOL-1-YL)-N,N-DIMETHYLPROPAN-1-AMINE AS AN ANTICANCER COMPOUND

3-(2-(4-METHOXYPYRIDIN-3-YL)-4,5-DIPHENYL-1H-IMIDAZOL-1-YL)-N,N-DIMETHYLPROPAN-1-AMINE AS AN ANTI-CANCER COMPOUND

Elagolix Sodium Compositions and Processes

PPARG INVERSE AGONISTS AND USES THEREOF

POLYMORPHIC FORM OF MEISOINDIGO AND MODIFIED FORMULATION OF MEISOINDIGO

NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF

IMPROVED PROCESS FOR THE PREPARATION OF UPADACITINIB

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM

SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE

NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES

3-NITRO-1,2,4-TRIAZOLE-5-ONE-D2, PREPARATION METHOD AND USE THEREOF

CRYSTAL FORMS OF 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE

CRYSTALLINE FORM OF TRIETHYLENETETRAMINE TETRAHYDROCHLORIDE AND ITS PHARMACEUTICAL USE

Improved synthesis of lysine acetylsalicylate - Glycine particles

CRYSTALLINE FORMS OF PENTAAZA MACROCYCLIC RING COMPLEX

SOLID STATE FORMS OF BELUMOSUDIL AND BELUMOSUDIL SALTS

SOLID STATE FORMS OF BELUMOSUDIL AND BELUMOSUDIL SALTS

Methods of Synthesis of Chiral 3,5-Disubstituted Morpholine Compounds and Intermediates Useful Therein

CRYSTALLINE FORMS OF A CANNABINOID RECEPTOR TYPE 1 (CB1) MODULATOR AND METHODS OF USE AND PREPARATION THEREOF

CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF

CRYSTALLINE AND AMORPHOUS FORMS OF A COMPOUND FOR THE TARGETED DEGRADATION OF ESTROGEN RECEPTOR

CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA

Crystalline Forms of a Pharmaceutical Compound

NUCLEOSIDE PHOSPHORAMIDATES

NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYPHENYLAZO)-2-NAPHTHOL (H2AZD) FOR BIOLOGICAL APPLICATIONS

NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYPHENYLAZO)-2-NAPHTHOL (H2AZD) FOR BIOLOGICAL APPLICATIONS

TEBIPENEM PIVOXIL CRYSTALLINE FORMS, COMPOSITIONS INCLUDING THE SAME, METHODS OF MANUFACTURE, AND METHODS OF USE

SALTS OF AN FGFR INHIBITOR

Crystalline forms of CFTR modulators

Process for Manufacturing Pibrentasvir Active Drug Substance

CRYSTALLINE BIS-MIPROCIN FUMARATE

CRYSTALLINE EPINEPHRINE MALONATE SALT

CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF

SALTS FOR MTOR COMPOUNDS

INHIBITORS OF APOL1 AND METHODS OF USING SAME

CRYSTAL FORM OF BLARCAMESINE HYDROCHLORIDE, METHOD FOR PREPARING SAME, AND USE THEROF

Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form

CRYSTALLINE SALTS OF N-ETHYL-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINE

PRODUCTION METHOD FOR AROMATIC HYDROXYCARBOXYLIC ACID CRYSTAL

Injectable Suspensions

POLYMORPHIC FORMS AND METHODS OF PRODUCING POLYMORPHIC FORMS OF A COMPOUND

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-1-METHYLETHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-7-YL]BIPHENYL-2-CARBONITRILE WITH PHOSPHORIC ACID AS GABAA POSITIVE ALLOSTERIC MODULATORS

SALTS AND SOLID FORMS OF A COMPOUND THAT MODULATES IRAK4

METHOD OF MANUFACTURING A SOLID FORM OF A BET BROMODOMAIN INHIBITOR

CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3-(TETRAHYDRO-2H-PYRAN-4-YL)-5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONE

CRYSTALLINE SUBSTITUTED PYRAZINES AS PGI2 RECEPTOR AGONISTS

COCRYSTALS OF NICOTINAMIDE RIBOSIDE SALTS, CRYSTALLINE FORMS, METHODS OF PREPARATION, AND APPLICATIONS THEREOF

ALUMINUM DIETHYLPHOSPHINATE CRYSTAL WITH LOW FINE POWDER CONTENT, PREPARATION METHOD THEREFOR AND USE THEREOF

CRYSTALLINE FORMS OF A PAR4 INHIBITOR

SOLID FORMS OF JAK INHIBITOR AND PROCESS OF PREPARING THE SAME

COCRYSTAL

FXR (NR1H4) MODULATING COMPOUNDS

PROCESS FOR PREPARING A BENZOATE SALT OF A 1-(3-AMINOPYRROLIDINE-1-CARBONYL)-3,4-DIPHENYLBENZENE COMPOUND

SALTS OF A PIM KINASE INHIBITOR

PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE ACETATE

R-MDMA CRYSTAL FORMS

L-LYSINE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF

Crystal Modifications of Odevixibat

CRYSTALLINE FORMS OF TROFINETIDE

Salts of Ruxolitinib and Crystalline Forms Thereof

PREPARATION AND USES OF OBETICHOLIC ACID

PSILOCYBIN AND O-ACETYLPSILOCIN, SALTS AND SOLID STATE FORMS THEREOF

Synthesis Process of X-IPM, Stable Crystal Form and Application Thereof

ORGANOTIN CLUSTERS, SOLUTIONS OF ORGANOTIN CLUSTERS, AND APPLICATION TO HIGH RESOLUTION PATTERNING

CRYSTALLINE FORMS OF A MCL-1 INHIBITOR, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

METHODS OF MAKING CANNABIDIVARIN ISOLATE

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

BORONIC ACID DERIVATIVES AND SYNTHESIS, POLYMORPHIC FORMS, AND THERAPEUTIC USES THEREOF

Methyl 2-(Fluoromethyl)-5-Oxo-4-Phenyl-4,5,6,7-Tetrahydro-1h-Cyclopenta[B]Pyridine-3-Carboxylate And Methyl 2- (Fluoromethyl0-5-Oxo-4-Phenyl-1,4,5,7-Tetrahydrofuro[3,4-B]Purodine-3-Carboxylate As Cav1.2 Activators

6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR

CRYSTAL OF PYRROLIDINE COMPOUND

SALTS AND SOLID FORMS OF (R)-1-(5-METHOXY-1H-INDOL-1-YL)-N,N-DIMETHYLPROPAN-2-AMINE

PHARMACEUTICALLY ACCEPTABLE SALT OF ELIGLUSTAT AND CRYSTAL FORM THEREOF

COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF

SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF

SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME

PLINABULIN COMPOSITIONS

SOLID STATE FORMS OF REPROXALAP

PROCESS FOR PRODUCING CRYSTALLINE L-CARNITINE

Methods for making and using endoxifen

Formulations of an AXL/MER inhibitor

SULFASALAZINE SALTS, PRODUCTION PROCESSES AND USES

CRYSTALLINE FORMS OF QUINAZOLINE DERIVATIVES, PREPARATION, COMPOSITION AND USE THEREOF

HYDROGEN SULFATE SALT OF A BCL-2 INHIBITOR, RELATED CRYSTALLINE FORM, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

CRYSTALS OF TETRAHYDRONAPHTHYL UREA DERIVATIVE

SALTS OF A HETEROCYCLIC COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF

FORMULATIONS OF T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF

3-HYDROXYPROPIONATE CRYSTAL, PREPARATION METHOD OF THE SAME AND PROCESS OF RECOVERING 3-HYDROXYPROPIONIC ACID

METHOD FOR MANUFACTURING SODIUM LACTATE SOLID PARTICLES AND USE THEREOF

CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATION THEREOF, AND METHODS OF MAKING AND USING SAME

SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE

Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the Same

PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

NOVEL CRYSTALLINE SALT FORMS OF MESEMBRINE

CRYSTALLINE PROSTACYCLIN (IP) RECEPTOR AGONIST AND USES THEREOF

SOLID FORM OF (-)-AMBROX FORMED BY A BIOCONVERSION OF HOMOFARNESOL IN THE PRESENCE OF A BIOCATALYST

SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS

CRYSTAL FORMS A, B, C, D, E, F AND G OF SELUMETINIB SULFATE AND PREPARATION METHODS THEREOF

CRYSTALLINE HYDROCHLORIDE SALTS OF N-ETHYL-2-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINE

(+)-3-(2,3-DIFLUOROPHENYL)-3-METHOXYPYRROLIDINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR PREPARATION THEREOF AND USES THEREOF

CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR

CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROPYRIDO [3,2-B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDE

CRYSTALLINE FORM OF TOLEBRUTINIB AND PREPARATION METHOD THEREOF

INTEGRIN INHIBITOR AND USES THEREOF

Processes and intermediates for the preparation of soluble guanylate cyclase stimulators

Substituted tetrahydrofurans as modulators of sodium channels

Salts of Obicetrapib and Processes for their Manufacture and Intermediates Thereof

Crystal form of pyrazolyl-amino-pyrimidinyl derivative, and preparation method therefor and use thereof

CO-CRYSTAL OR SALT

METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Crystalline forms of a KRas G12C inhibitor

PROCESS OF MAKING SOMATOSTATIN MODULATORS

CRYSTALLINE FORMS OF (S, E)-4-(DIMETHYLAMINO)-N-(3-(4-(2-HYDROXY-1-PHENYLETHYLAMINO)-6-PHENYLFURO[2,3-D]PYRIMIDIN-5-YL)PHENYL)BUT-2-ENAMIDE FREE BASE

BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF

NOVEL CRYSTALLINE FORMS OF A NUCLEOSIDE COMPOUND AND SALTS THEREOF

VALORISATION OF LACTIC ACID STREAM IN THE PRODUCTION PROCESS OF POLYLACTIC ACID

METHOD FOR PRODUCING FUNCTIONAL CRYSTALLINE SWEETENER

SALTS AND SOLID FORMS OF A COMPOUND HAVING GLP-1 AGONIST ACTIVITY

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Bicyclic Compounds and their Uses

PHARMACEUTICAL SALTS OF A CHK-1 INHIBITOR

Crystalline Solids of 3-Palmitoyl-Amido-1,2-Propanediol and 3-Palmitoyl-Amido-2-Hydroxy-1-Dimethoxytriphenylmethylether-Propane and Methods of Making and Using the Same

CRYSTALLINE FORM OF TRIETHYLENETETRAMINE TETRAHYDROCHLORIDE AND ITS PHARMACEUTICAL USE

Polymorphic compounds and uses thereof

SALT AND CRYSTAL FORM OF EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF

CRYSTAL FORM OF RIPK1 INHIBITOR, ACID SALT THEREOF, AND CRYSTAL FORM OF ACID SALT THEREOF

HYDROXYPYRIDOXAZEPINES AS NRF2 ACTIVATORS

METHODS OF TREATING PAINFUL DIABETIC PERIPHERAL NEUROPATHY

PROCESSES FOR THE PREPARATION OF FURAZANOBENZIMIDAZOLES AND CRYSTALLINE FORMS THEREOF

STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-2-(2,2-DIMETHYLPROPYL)-1H-1,3-BENZODIAZOL-5-YL}SULFONYL)AZETIDIN-1-YL]ETHAN-1-OL

CRYSTALLINE NORPSILOCIN COMPOUNDS

CRYSTALLINE FORMS OF AN IRREVERSIBLE INHIBITOR OF MENIN-MLL INTERACTION

SOLID FORMS OF A DUAL RAF/MEK INHIBITOR

1-PYRAZOLYL-3- (4- ((2 -ANILINOPYRIMIDIN- 4 - YL) OXY) NAPTHTHALEN- I - YL) UREAS AS P38 MAPKINASE INHIBITORS

COCRYSTALS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF TREATMENT INVOLVING SAME

COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF

PHARMACEUTICALLY ACCEPTABLE SALTS OF [2-(3-FLUORO-5-METHANE-SULFONYL-PHENOXY)ETHYL](PROPYL)AMINE AND USES THEREOF

MODULATORS OF ALPHA-1 ANTITRYPSIN

R-KETAMINE SALTS AND METHODS OF USE THEREOF

Polymorphs of phenyl pyrrole aminoguandium salts

SALTS AND SOLID STATE FORMS OF A KIF18A INHIBITOR COMPOUND

LENALIDOMIDE PROCESS

PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF

CRYSTALLINE FORMS OF COMPOSITIONS COMPRISING PSILOCIN AND PSILOCYBIN

PROCESS FOR THE PRODUCTION OF LEVETIRACETAM

Methods for making and using endoxifen

Compounds and methods for treatment of viral infections

PROCESS FOR THE SYNTHESIS OF 4-((R)-2-{[6-((S)-3-METHOXY-PYRROLIDIN-1-YL)-2-PHENYL-PYRIMIDINE-4-CARBONYL]-AMINO}-3-PHOSPHONO-PROPIONYL)-PIPERAZINE-1-CARBOXYLIC ACID BUTYL ESTER

SOLID FORMS OF 4-(3,3-DIFLUORO-2,2-DIMETHYL-PROPANOYL)-3,5-DIHYDRO-2H-PYRIDO[3,4-F][1,4]OXAZEPINE-9-CARBONITRILE

SOLID FORMS, PHARMACEUTICAL COMPOSITIONS AND PREPARATION OF HETEROAROMATIC MACROCYCLIC ETHER COMPOUNDS

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

CRYSTALLINE FORMS OF C-C CHEMOKINE RECEPTOR TYPE 4 ANTAGONIST AND USES THEREOF

PROCESSES FOR THE PREPARATION OF 4-{8-AMINO-3-[(2S)-1-(BUT-2-YNOYL)-PYRROLIDIN-2-YL]IMIDAZO[1,5-a]-PYRAZIN-1-YL}N-(PYRIDIN-2-YL)-BENZAMIDE

SALTS AND SOLID FORMS OF A COMPOUND HAVING APJ RECEPTOR ACTIVITY

SOLID FORMS OF ISOQUINOLINONES, AND PROCESS OF MAKING, COMPOSITION COMPRISING, AND METHODS OF USING THE SAME

PURINONE DERIVATIVE HYDROCHLORIDE

SOLID FORMS OF 3-((1R,3R)-1-(2,6-DIFLUORO-4-((1-(3-FLUOROPROPYL)AZETIDIN-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-B]INDOL-2-YL)-2,2-DIFLUOROPROPAN-1-OL AND PROCESSES FOR PREPARING FUSED TRICYCLIC COMPOUNDS COMPRISING A SUBSTITUTED PHENYL OR PYRIDINYL MOIETY, INCLUDING METHODS OF THEIR USE

COMPOUNDS AND METHODS OF PREPARING COMPOUNDS S1P1 MODULATORS

PYRROLIDINE AMIDE DERIVATIVE SALT AND USE THEREOF

METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME

Forms of aticaprant

CRYSTALLINE SOLID FORMS OF A BET INHIBITOR

Process for Preparing an FGFR Inhibitor

POLYMORPHS OF AN SSAO INHIBITOR

CRYSTALLINE FORMS OF PENTAAZA MACROCYCLIC RING COMPLEX

SOLID FORMS OF PYRAZOLO[3,4-D]PYRIMIDINE COMPOUNDS

CRYSTALLINE FORMS AND SALT FORMS OF A KINASE INHIBITOR

Solid forms

MATERIALS AND METHODS FOR IODINE CAPTURE

CRYSTALLINE FORMS OF A DIFFUSION ENHANCING COMPOUND

CRYSTALLIZATION OF HIGH-PURITY MAGNESIUM L-LACTATE

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

SODIUM N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLATE POLYMORPHIC FORM A

NOVEL CRYSTALLINE FORMS OF [(1R)-2-(1-BENZOFURAN-3-YL)-1-{[(1S,2R,4R)-7-OXABICYCLO[2.2.1]HEPTAN-2-YL]FORMAMIDO}ETHYL]BORONIC ACID, ADDUCTS THEREOF, AND PROCESSES TO OBTAIN

SOLID STATE FORMS OF LUMATEPERONE SALTS AND PROCESSES FOR PREPARATION OF LUMATEPERONE AND SALTS THEREOF

Crystalline Forms of a Pharmaceutical Compound

ACETYLSALICYLIC ACID DERIVATIVE AND APPLICATION THEREOF

METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME

Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide

SALT OF AN AMINOPYRIDINE DERIVATIVE COMPOUND, A CRYSTALLINE FORM THEREOF, AND A PROCESS FOR PREPARING THE SAME

SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR

CRYSTALLINE POLYMORPHS OF RIGOSERTIB SODIUM

PREPARATION METHOD OF CAROTENOID AGENT

CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE

METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS

GLYCERIC ACID, GLYCERATE, AND COMPOSITION THEREOF

Solid Forms, Salts and Polymorphs of Anti-fibrotic Compounds

PHARMACEUTICAL SALT OF FINGOLIMOD, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF

CO-CRYSTAL OF CITRIC ACID AND GLYCINE AND USES THEREOF

METHODS OF MAKING METAL-ORGANIC FRAMEWORKS WITH PRE-LIGANDS

POLYMORPHIC FORM OF TG02 FOR TREATING CANCER

POLYMORPHIC FORM OF TG02 FOR TREATING CANCER

SOLID FORMS OF AN HIV CAPSID INHIBITOR

PROCESS FOR MAKING AMINO DIARYL ETHERS AND AMINO DIARYL ETHERS HYDROCHLORIDE SALTS

TANK USED IN REFINING DEVICE

METHOD FOR TREATING ANXIETY DISORDERS, HEADACHE DISORDERS, AND EATING DISORDERS WITH PSILOCYBIN

CRYSTAL FORMS OF KUDING SAPONIN A COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF

SOLID FORMS OF AN SGC STIMULATOR

CRYSTALLINE FORM OF TRICYCLIC DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

Process for Preparing Large Size Isoxazoline Particles

CRYSTALLINE SALTS OF PSILOCIN

NOVEL METHODS

CRYSTALLINE POLYMORPHS OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR, AND COMPOSITIONS AND METHODS THEREOF

SALTS OF 2-BROMOLYSERGIC ACID DIETHYLAMIDE

CO-CRYSTAL OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND VANILLIN AND METHOD FOR PREPARING SAME

PROCESSES FOR PREPARING AG-10, ITS INTERMEDIATES, AND SALTS THEREOF

ACID ADDITION SALT OF ROCK INHIBITOR, AND CRYSTAL FORM, COMPOSITION AND PHARMACEUTICAL USE THEREOF

Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine

Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide

2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

TERTIARY ALCOHOLS AS PI3K-y INHIBITORS

SOLID FORMS OF EMETINE

Solid state forms of mavacamten and process for preparation thereof

BRANCHED-CHAIN AMINO ACID CRYSTALLIZATION METHOD CAPABLE OF SUSTAINABLY CYCLING AMMONIA

BIS(FLUOROSULFONYL)IMIDE SALTS AND PREPARATION METHOD THEREOF

PYRIMIDINYLAMINOBENZENES FOR LUNG CANCER TREATMENT

TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER

SOLID FORMS OF (R)-OXYBUTYNIN D-MALATE

SYNTHETIC CO-CRYSTALS OF ANHYDROUS GUANINE AND PROCESS FOR PREPARING THE SAME

CRYSTALLINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONIST

POLYMORPHS OF SELINEXOR

SOLID STATE FORMS OF TAPINAROF

LAMOTRIGINE HYDRATE CRYSTAL FORM, PREPARATION METHOD THEREFOR, AND COMPOSITION CONTAINING SAME

MORPHIC FORMS OF 4-AMINO-7-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2-METHYL-7H-PYRROLO[2,3-d]PYRIMIDINE-5-CARBOXAMIDE AND USES THEREOF

PREPARATION OF PSILOCYBIN, DIFFERENT POLYMORPHIC FORMS, INTERMEDIATES, FORMULATIONS AND THEIR USE

MONOHYDRATE AND CRYSTALLINE FORMS OF 6-[(3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL]-3-TETRAHYDROPYRAN-4-YL-7H-IMIDAZO[1,5-A]PYRAZIN-8-ONE

Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

Crystal form F of trelagliptin and preparation method thereof

POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF

SALTS AND CRYSTAL FORMS OF OMECAMTIV MECARBIL

CRYSTALLINE SALTS OF PSILOCIN

Novel Chlorhexidine Salts and Related Compositions and Methods

Salts and esters of APX3330 and therapeutic uses thereof

RXR AGONIST SALT FORM, POLYMORPHS THEREOF, AND USES THEREOF

ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS

HEMI-CITRATE SALTS OF GABA-A POSITIVE ALLOSTERIC MODULATOR AND CRYSTALLINE FORM THEREOF

SOLID FORMS OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME

Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile

CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

Crystalline forms of psilacetin

Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof

PHARMACEUTICAL FORMULATIONS OF TROPOMYOSIN RELATED KINASE (TRK) INHIBITORS

Crystalline Forms 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- Enenitrile

CRYSTALLINE FORMS OF AN MK2 INHIBITOR

Crystal forms of immunomodulators

SOLID DOSAGE FORMS OF A PLASMA KALLIKREIN INHIBITOR

QUINOLINE COMPOUND SALT OR CRYSTAL FORM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

A PROCESS FOR THE PREPARATION OF MIXED OXYBATE SALTS AND POLYMORPHS THEREOF

METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME

Substituted pyridines as DNMT1 inhibitors

SOLID FORMS OF A COMPOUND FOR MODULATING COT

MAP4K1 INHIBITORS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

COMPOUNDS FOR THE TREATMENT OF DISORDERS AND SALTS AND POLYMORPHS THEREOF

Crystals

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

PROCESS AND INTERMEDIATES FOR PREPARING A JAK INHIBITOR

CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME

HDAC inhibitor solid state forms

PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR

CRYSTALLINE 4-HYDROXY-N,N-DI-N-PROPYLTRYPTAMMONIUM (4-HO-DPT) SALTS

METHOD FOR PRODUCING FORM-II TYPE REDUCED COENZYME Q10 CRYSTAL OR CRYSTALLINE SOLID OF SAME, AND CRYSTALLIZING APPARATUS

NOVEL SALTS OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS

MODULATORS OF ALPHA-1 ANTITRYPSIN

PROCESS FOR MAKING A PD-1/PD-L1 INHIBITOR AND SALTS AND CRYSTALLINE FORMS THEREOF

Pyrimidine compound as JAK kinase inhibitor

CRYSTALLINE FORMS, COMPOSITIONS CONTAINING SAME, AND METHODS OF THEIR USE

Synthesis of a Monoacylglycerol Lipase Inhibitor

PRODUCTION METHOD FOR REDUCED COENZYME Q10 FORM-II TYPE CRYSTAL OR CRYSTALLINE SOLID THEREOF

Heterocyclic compounds, preparation methods and uses thereof

ELECTRON WITHDRAWING GROUP (EWG)-CONTAINING ORGANIC MOLECULES FOR IMPROVED OPTICAL PROPERTIES IN AR/VR COMPONENTS